E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

Clinical trial NCT05639972 · RECRUITING

Trial details

NCT number: NCT05639972
Sponsor: Christian Hinrichs
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HPV-Associated Cervical Carcinoma HPV-Related Carcinoma HPV-Related Malignancy HPV Positive Oropharyngeal Squamous Cell Carcinoma HPV-Related Adenocarcinoma HPV-Related Adenosquamous Carcinoma HPV-Related Squamous Cell Carcinoma HPV-Related Anal Squamous Cell Carcinoma HPV-Related Penile Squamous Cell Carcinoma HPV-Related Vulvar Squamous Cell Carcinoma HPV-Related Endocervical Adenocarcinoma Cervical Cancer

Start date: 2025-08-11
Primary completion: 2026-10-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.